Identification of Surrogate Outcome Biomarkers in Lung Allograft Recipients With Bronchiolitis Obliterans: Implications for Randomized Controlled Trials

The rate of FEV<sub>1</sub> decline quantified using at least 5 FEV<sub>1</sub> measurements is a robust surrogate outcome. We plan to use these findings to revise our randomized controlled trial to facilitate risk adjustment using FEV<sub>1</sub> rate of decline strata at enrollment and as a scientifically valid surrogate for outcome.

Authors

Institutions

Publication Details

Journal
Transplantation Direct
Published
2025-09-19
DOI
https://doi.org/10.1097/txd.0000000000001857
Primary Topic
Transplantation: Methods and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Identification of Surrogate Outcome Biomarkers in Lung Allograft Recipients With Bronchiolitis Obliterans: Implications for Randomized Controlled Trials

Mrunal Patel, Shambhu Aryal, Keith Berman, Howard J. Huang et al.
Transplantation Direct
Transplantation: Methods and Outcomes
article

Identification of Surrogate Outcome Biomarkers in Lung Allograft Recipients With Bronchiolitis Obliterans: Implications for Randomized Controlled Trials

Mrunal Patel, Shambhu Aryal, Keith Berman, Howard J. Huang, Nicole De Simone, John M. Reynolds, Hilary J. Goldberg, Elizabeth A. Lendermon, Keith Wille, Jeffrey J. Atkinson, Rajat Walia, Amena Usmani, George J. Despotis, Selim M. Arcasoy, Gordon Yung, Andrew Atkinson, Brian C. Keller, Chadi A. Hage, Mary Clare Derfler, Derek E. Byers, Jagadish Patil, А. В. Прокудин, Francis Cordova, David R. Nunley, John E. McCarthy, Julia Klesney‐Tait, Suresh Vedantham, Paul K. Commean, Kevin M. Chan, Ramsey R. Hachem, Reda E. Girgis, Andrés Peláez, Chetan Naik, M. Baz, Matthew R. Morrell, Amir Emtazoo
article en

Abstract

The rate of FEV<sub>1</sub> decline quantified using at least 5 FEV<sub>1</sub> measurements is a robust surrogate outcome. We plan to use these findings to revise our randomized controlled trial to facilitate risk adjustment using FEV<sub>1</sub> rate of decline strata at enrollment and as a scientifically valid surrogate for outcome.

Transplantation DirectVol. 11(10)
Washington University in St. Louis (US), University of Utah (US), Dignity Health (US)
Openalex Percentile: Top 59%
Transplantation: Methods and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.